NEW YORK (GenomeWeb News) – Gene synthesis firm Geneart said Friday that it planned to issue bonus shares in a 1:1 ratio in order to double its number of tradable shares. 
Geneart, based in Regensburg, Germany, is listed on the German Stock Exchange.
The company said that the issue of bonus shares is comparable to a 1:1 stock split. It doubles the number of shares for each account, while the price of each share is halved.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.